Artificial Intelligence: Difference between revisions
Jump to navigation
Jump to search
ps>Pallav No edit summary |
ps>Pallav No edit summary |
||
| Line 4: | Line 4: | ||
*[http://www.recursionpharma.com/approach.html Recursion Pharmaceuticals]: Drug discovery using AI. $13.2M in 3 rounds. | *[http://www.recursionpharma.com/approach.html Recursion Pharmaceuticals]: Drug discovery using AI. $13.2M in 3 rounds. | ||
*[http://www.gnshealthcare.com/our-approach/ GNS Healthcare]: Machine learning applied for precision medicine. Solutions around patient segmentation, drug discovery. $43M raised. | *[http://www.gnshealthcare.com/our-approach/ GNS Healthcare]: Machine learning applied for precision medicine. Solutions around patient segmentation, drug discovery. $43M raised. | ||
*[http://www.kensci.com KenSci]: Risk stratification of patient populations using ML. UW Tacoma professor founder. $8.5M raised. | |||
Revision as of 12:16, 30 January 2017
- AI Cure: Applying machine learning and computer vision to medication adherence. Smartphone camera can verify if the patient took medication. Raised $15M+.
- Atomwise: Drug discovery using AI. Raised $6M+
- Cardiogram: Ex-google founders, applying deep learning to mobile health data. Backed by Andreessen Horowitz.
- Recursion Pharmaceuticals: Drug discovery using AI. $13.2M in 3 rounds.
- GNS Healthcare: Machine learning applied for precision medicine. Solutions around patient segmentation, drug discovery. $43M raised.
- KenSci: Risk stratification of patient populations using ML. UW Tacoma professor founder. $8.5M raised.